Literature DB >> 26671120

Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.

Yasuaki Mizutani1, Shinji Ito1, Kenichiro Murate1, Seiko Hirota1, Takao Fukui1, Chika Hikichi1, Tomomasa Ishikawa1, Sayuri Shima1, Akihiro Ueda1, Madoka Kizawa1, Kunihiko Asakura1, Tatsuro Mutoh2.   

Abstract

BACKGROUND: Although most patients with Parkinson's disease (PD) show decreased cardiac (123)I-metaiodobenzylguanidine (MIBG) uptake, some exhibit normal uptake. We evaluated the clinical characteristics of such patients.
METHODS: We enrolled 154 non-demented patients showing parkinsonism with normal cardiac MIBG uptake and had been clinically followed up during 29.9 ± 27.6 months. We defined the patients who did not fit the exclusion criteria for PD and demonstrated ≥ 30% reduction in the Unified Parkinson's Disease Rating Scale (UPDRS) motor score after anti-Parkinson agent administration as probable PD. We compared clinical characteristics and the cardiac MIBG heart-to-mediastinum (H/M) ratio between the probable PD group (N=37) and other groups (N=117).
RESULTS: The probable PD group showed significantly higher UPDRS motor scores and greater incidence of tremor/rigidity than those of other groups. In addition, they showed a significantly lower cardiac MIBG H/M ratio in the delayed phase (delayed, p<0.0001). Washout-rate (WR) was significantly higher in probable PD cases (p<0.0001). Among 16 probable PD patients undergoing serial cardiac MIBG scintigraphy, the delayed phase cardiac MIBG H/M ratio showed a significant decrease and WR significantly increased during follow-up periods.
CONCLUSIONS: An increase in WR and lower delayed phase cardiac MIBG uptake were found to be characteristics of such patients.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac (123)I-metaiodobenzylguanidine scintigraphy ((123)I-MIBG); Cardiovascular dysautonomia; Cut-off value; Parkinson's disease; Parkinsonian syndrome; Receiver operator characteristic (ROC) curve; Washout-rate

Mesh:

Substances:

Year:  2015        PMID: 26671120     DOI: 10.1016/j.jns.2015.10.059

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm.

Authors:  J William Langston; Jesse C Wiley; Michele Tagliati
Journal:  NPJ Parkinsons Dis       Date:  2018-02-23

2.  Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Authors:  M A Qamar; A Sauerbier; M Politis; H Carr; P Loehrer; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2017-01-25

3.  Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.

Authors:  Young Jin Jeong; Ji-Eun Jeong; Sang-Myung Cheon; Byeol-A Yoon; Jae Woo Kim; Do-Young Kang
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.